- August 2, 2022
- Newsletter
- 617-430-5616
Menu
Brand Name :
Trandate
Synonyms :
labetalol
Class :
Antihypertensive and alpha/beta-blockers
Dosage Forms & Strengths
Injectable solution
5mg/ml
Tablet
100mg
200mg
300mg
100
mg
Orally
every 12 hrs
initially; increased up to100 mg for 12hrs every 2-3 days Usual dosage range: 200-400 mg orally every 12hrs Do not exceed 2400 mg per day
20
mg
Intravenous (IV)
over 2 minutes initially
then 40-80 mg IV for every 10min
Do not exceed 300 mg per day
Dosage Forms & Strengths
Injectable solution
5mg/ml
Tablet
100mg
200mg
300mg
0.4 - 1
mg/kg
per hour by continuous IV infusion
do not exceed 3 mg/kg per hour
13
mg/kg
Orally
once a day
or divided for every 12hr
do not exceed 1200 mg per day
bradycardia-Causing Agents may enhance the bradycardic effect of Ceritinib
bradycardia-Causing Agents may enhance the bradycardic effect of ponesimod
may increase the bradycardic effect of bradycardia-causing agents
may have an increased bradycardic effect when combined with fingolimod
may have an increased bradycardic effect when combined with ponesimod
may have an increased bradycardic effect when combined with siponimod
may decrease the diagnostic effect when combined with benzylpenicilloyl polylysine
may have an increased hypertensive effect when combined with alpha1-blockers
may increase the risk of adverse effects
may increase the risk of adverse effects
may increase the risk of adverse effects
may increase the risk of adverse effects
may increase the risk of adverse effects
may enhance the hypotensive effect of phosphodiesterase 5 Inhibitors
may increase the vasoconstricting effect of Ergot Derivatives
may increase the hypotensive effect of alpha1-blockers
may increase the hypotensive effect of alpha1-blockers
may increase the hypotensive effect of alpha1-blockers
may increase the hypotensive effect of alpha1-blockers
may increase the hypotensive effect of alpha1-blockers
clozapine: they may increase the bradycardic effect of Bradycardia-Causing Agents
secretin: they may increase the bradycardic effect of Bradycardia-Causing Agents